Pituitary adenylate cyclase-activating polypeptide produces a phase shift associated with induction of mPer expression in the mouse suprachiasmatic nucleus

Y. Minami, K. Furuno, M. Akiyama, T. Moriya, Shigenobu Shibata

    Research output: Contribution to journalArticle

    31 Citations (Scopus)

    Abstract

    The main mammalian circadian pacemaker is located in the suprachiasmatic nucleus of the hypothalamus. Clock genes such as the mouse Period gene (mPer) play a role in this core clock mechanism in the mouse. With brief light exposure during the subjective night, the photic information, which is conveyed directly to the suprachiasmatic nucleus via the retinohypothalamic tract, results in mPer1 and mPer2 expression in the suprachiasmatic nucleus. Glutamate and pituitary adenylate cyclase-activating polypeptide (PACAP) are co-stored in the retinohypothalamic tract. Recent studies have suggested that not only glutamate but also PACAP are key players in the phase shift that occurs during subject night; however, research demonstrating a direct association between the PACAP-induced phase shift and mPer gene expression has yet to be conducted. In the present study, PACAP (200 pmol) injected into the lateral ventricle during subjective night (circadian time 16; circadian time 12, onset of locomotor activity) caused a moderate phase delay associated with moderate expression of mPer1 and only slight expression of mPer2 in the mouse suprachiasmatic nucleus. PACAP-induced mPer1 expression was also observed in the paraventricular nucleus and periventricular area of the hypothalamus. (+)MK-801 (0.5 mg/kg), an N-methyl-D-aspartate (NMDA) receptor antagonist, suppressed both the PACAP-induced phase delay and mPer1 expression. From these results we suggest that PACAP induces phase delays in the mouse circadian rhythm in association with an increase of mPer expression in the suprachiasmatic nucleus via the activation of NMDA receptors.

    Original languageEnglish
    Pages (from-to)37-45
    Number of pages9
    JournalNeuroscience
    Volume113
    Issue number1
    DOIs
    Publication statusPublished - 2002 Aug 2

    Fingerprint

    Pituitary Adenylate Cyclase-Activating Polypeptide
    Suprachiasmatic Nucleus
    Gene Expression
    N-Methyl-D-Aspartate Receptors
    Hypothalamus
    Glutamic Acid
    Genes
    Dizocilpine Maleate
    Paraventricular Hypothalamic Nucleus
    Lateral Ventricles
    Locomotion
    Circadian Rhythm
    Light
    Research

    Keywords

    • (+)MK-801
    • Circadian rhythm
    • Entrainment
    • i.c.v. injection
    • NMDA receptor

    ASJC Scopus subject areas

    • Neuroscience(all)

    Cite this

    Pituitary adenylate cyclase-activating polypeptide produces a phase shift associated with induction of mPer expression in the mouse suprachiasmatic nucleus. / Minami, Y.; Furuno, K.; Akiyama, M.; Moriya, T.; Shibata, Shigenobu.

    In: Neuroscience, Vol. 113, No. 1, 02.08.2002, p. 37-45.

    Research output: Contribution to journalArticle

    @article{9fa09a26ff7445129292bb8aa1e914da,
    title = "Pituitary adenylate cyclase-activating polypeptide produces a phase shift associated with induction of mPer expression in the mouse suprachiasmatic nucleus",
    abstract = "The main mammalian circadian pacemaker is located in the suprachiasmatic nucleus of the hypothalamus. Clock genes such as the mouse Period gene (mPer) play a role in this core clock mechanism in the mouse. With brief light exposure during the subjective night, the photic information, which is conveyed directly to the suprachiasmatic nucleus via the retinohypothalamic tract, results in mPer1 and mPer2 expression in the suprachiasmatic nucleus. Glutamate and pituitary adenylate cyclase-activating polypeptide (PACAP) are co-stored in the retinohypothalamic tract. Recent studies have suggested that not only glutamate but also PACAP are key players in the phase shift that occurs during subject night; however, research demonstrating a direct association between the PACAP-induced phase shift and mPer gene expression has yet to be conducted. In the present study, PACAP (200 pmol) injected into the lateral ventricle during subjective night (circadian time 16; circadian time 12, onset of locomotor activity) caused a moderate phase delay associated with moderate expression of mPer1 and only slight expression of mPer2 in the mouse suprachiasmatic nucleus. PACAP-induced mPer1 expression was also observed in the paraventricular nucleus and periventricular area of the hypothalamus. (+)MK-801 (0.5 mg/kg), an N-methyl-D-aspartate (NMDA) receptor antagonist, suppressed both the PACAP-induced phase delay and mPer1 expression. From these results we suggest that PACAP induces phase delays in the mouse circadian rhythm in association with an increase of mPer expression in the suprachiasmatic nucleus via the activation of NMDA receptors.",
    keywords = "(+)MK-801, Circadian rhythm, Entrainment, i.c.v. injection, NMDA receptor",
    author = "Y. Minami and K. Furuno and M. Akiyama and T. Moriya and Shigenobu Shibata",
    year = "2002",
    month = "8",
    day = "2",
    doi = "10.1016/S0306-4522(02)00148-3",
    language = "English",
    volume = "113",
    pages = "37--45",
    journal = "Neuroscience",
    issn = "0306-4522",
    publisher = "Elsevier Limited",
    number = "1",

    }

    TY - JOUR

    T1 - Pituitary adenylate cyclase-activating polypeptide produces a phase shift associated with induction of mPer expression in the mouse suprachiasmatic nucleus

    AU - Minami, Y.

    AU - Furuno, K.

    AU - Akiyama, M.

    AU - Moriya, T.

    AU - Shibata, Shigenobu

    PY - 2002/8/2

    Y1 - 2002/8/2

    N2 - The main mammalian circadian pacemaker is located in the suprachiasmatic nucleus of the hypothalamus. Clock genes such as the mouse Period gene (mPer) play a role in this core clock mechanism in the mouse. With brief light exposure during the subjective night, the photic information, which is conveyed directly to the suprachiasmatic nucleus via the retinohypothalamic tract, results in mPer1 and mPer2 expression in the suprachiasmatic nucleus. Glutamate and pituitary adenylate cyclase-activating polypeptide (PACAP) are co-stored in the retinohypothalamic tract. Recent studies have suggested that not only glutamate but also PACAP are key players in the phase shift that occurs during subject night; however, research demonstrating a direct association between the PACAP-induced phase shift and mPer gene expression has yet to be conducted. In the present study, PACAP (200 pmol) injected into the lateral ventricle during subjective night (circadian time 16; circadian time 12, onset of locomotor activity) caused a moderate phase delay associated with moderate expression of mPer1 and only slight expression of mPer2 in the mouse suprachiasmatic nucleus. PACAP-induced mPer1 expression was also observed in the paraventricular nucleus and periventricular area of the hypothalamus. (+)MK-801 (0.5 mg/kg), an N-methyl-D-aspartate (NMDA) receptor antagonist, suppressed both the PACAP-induced phase delay and mPer1 expression. From these results we suggest that PACAP induces phase delays in the mouse circadian rhythm in association with an increase of mPer expression in the suprachiasmatic nucleus via the activation of NMDA receptors.

    AB - The main mammalian circadian pacemaker is located in the suprachiasmatic nucleus of the hypothalamus. Clock genes such as the mouse Period gene (mPer) play a role in this core clock mechanism in the mouse. With brief light exposure during the subjective night, the photic information, which is conveyed directly to the suprachiasmatic nucleus via the retinohypothalamic tract, results in mPer1 and mPer2 expression in the suprachiasmatic nucleus. Glutamate and pituitary adenylate cyclase-activating polypeptide (PACAP) are co-stored in the retinohypothalamic tract. Recent studies have suggested that not only glutamate but also PACAP are key players in the phase shift that occurs during subject night; however, research demonstrating a direct association between the PACAP-induced phase shift and mPer gene expression has yet to be conducted. In the present study, PACAP (200 pmol) injected into the lateral ventricle during subjective night (circadian time 16; circadian time 12, onset of locomotor activity) caused a moderate phase delay associated with moderate expression of mPer1 and only slight expression of mPer2 in the mouse suprachiasmatic nucleus. PACAP-induced mPer1 expression was also observed in the paraventricular nucleus and periventricular area of the hypothalamus. (+)MK-801 (0.5 mg/kg), an N-methyl-D-aspartate (NMDA) receptor antagonist, suppressed both the PACAP-induced phase delay and mPer1 expression. From these results we suggest that PACAP induces phase delays in the mouse circadian rhythm in association with an increase of mPer expression in the suprachiasmatic nucleus via the activation of NMDA receptors.

    KW - (+)MK-801

    KW - Circadian rhythm

    KW - Entrainment

    KW - i.c.v. injection

    KW - NMDA receptor

    UR - http://www.scopus.com/inward/record.url?scp=0037008368&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0037008368&partnerID=8YFLogxK

    U2 - 10.1016/S0306-4522(02)00148-3

    DO - 10.1016/S0306-4522(02)00148-3

    M3 - Article

    C2 - 12123682

    AN - SCOPUS:0037008368

    VL - 113

    SP - 37

    EP - 45

    JO - Neuroscience

    JF - Neuroscience

    SN - 0306-4522

    IS - 1

    ER -